Depression is an increasingly common issue in the United States. The Centers for
Disease Control in 2010 estimated that 11.1 percent of the American population suffers
from significant depression — a whopping 35 million individuals — and this figure
seems to be steadily rising. Prescribed mood modifiers are everywhere, starting as
early as elementary school and continuing on into old age. How successful are these pharmacologic approaches? Not very. Optimistic estimates maintain that such interventions are reasonably successful in
only one half of those treated. Less optimistic observers note
that in those currently taking an SSRI (selective serotonin
reuptake inhibitor) antidepressant drugs such as Prozac,
despite a host of side effects, most do not attain relief. Nearly
two-thirds of elderly patients treated for depression fail to
achieve symptomatic remission and functional recovery with
first-line pharmacotherapy; they obtain better results with, for
instance, tai chi.1 For major depressive disorder, a condition
for which one would think that pharmacological treatments
would win out over nonpharmacological therapy, it turns out
that nonpharmacological therapy not only is just as effective,
but also involves far fewer adverse events.2,3
The causes of depression and mood disorders remain an
area of controversy. Human beings are prepared to react to
vastly varied environmental factors. Not surprisingly, many
biological and psychological factors cut in more than one
direction. Metabolic factors (inflammation, insulin resistance,
and oxidative stress) are not necessarily one-direction in terms
of causation, for example, with regard to emotional and physical
stress and the resulting stress hormones (glucocorticoids). Sex
hormones (testosterone, estrogen), likewise, both influence
and are influenced by emotional and physical factors.
Is Inflammation the Central Issue?
The concept of inflammation in the last few years has been
stretched to cover more and more forms of illness and
dysfunction. One reason is that inflammation is actually a set
of responses that occur naturally all the time, yet each of which
can itself escape proper regulation. You get a sense of this from
the article on inflammation available online from Wikipedia:
“Inflammation is a protective response that involves immune
cells, blood vessels, and molecular mediators. The purpose of
inflammation is to eliminate the initial cause of cell injury, clear
out necrotic cells and tissues damaged from the original insult
and the inflammatory process, and to initiate tissue repair.”
Inflammation thus involves both destruction and repair.
A number of researchers are looking into the issue of
neuroinflammation outside of the traditional medical areas of
concern, such as stroke. For instance, psychological stress has
been demonstrated to increase neuroinflammation in animal
models.4 Similarly, there is evidence to support the position
that links chronic depression to chronic brain inflammation and
acute depression to stress-triggered neuronal microdamage.5
Another line of argument is that the “metabolic syndrome
and its individual components induce a proinflammatory
state that damages blood vessels. This condition of chronic
inflammation may damage the vasculature of the brain or be
directly neurotoxic.”6
Countering Depression without Drugs
Inflammation and the metabolic syndrome are closely linked in
physiology and biochemistry. Therefore, it should not come as
a surprise that studies on obesity, diet and exercise habits often
turn up implications for preventing and treating depression.
For example, a large study of 15,093 people published in 2015
indicated that depression could be linked with nutrient deficits.
The best results were found with two essentially Mediterranean-style
diets. These diets overlapped in terms of foods such as
omega-3 fatty acids, vegetables, fruits, legumes, nuts and
moderate alcohol intake. Another finding was that there
apparently is a threshold effect, meaning that a certain level
of protective foods needed to be in the diet, but that benefits
in terms of reduced risk of depression plateaued after this
threshold was passed.7
It is difficult to find many nutrients that can be given as
dietary supplements that cross the blood-brain barrier. Many
of the nutrients that are of use are from berries. Pterostilbene,
but not resveratrol, is a potent neuromodulator in aging and
Alzheimer’s disease.8 “Blueberry, strawberry, blackberry, grape
and plum juices or extracts have been successfully tested in
cognitively impaired rodents. Published trials of the benefits of
grape and blueberry juice in the treatment of small numbers of
cognitively impaired persons have recently appeared.”9 Another
potentially useful item in this regard is the Chinese herb known
as blue dogbane, Apocynum venetum. This interesting item,
virtually unknown outside of Asia, exerts proven anti-depressant
effects, in part, via brain monoamine levels and the dopaminergic
system. The latter, again, is influenced by pterostilbene, but not
resveratrol.10 Of importance regarding the impact of Apocynum
venetum on inflammation is its high content of the potent
antioxidant / anti-inflammatory, isoquercitrin.11
A complementary option to the foregoing nutrients is to
reduce the impact of stress. Phosphatidylserine (PS) supports
the brain’s physiological processing of stress and promotes
neuronal communication by its effect on cell membrane fluidity.
It is a natural phospholipid that is an essential component of
cell membranes. PS promotes brain function by increasing
neuronal membrane fluidity (cell-to-cell communication),
resulting in improved cognition. Also, PS protects against stress
by mitigating the actions of cortisol (catabolic stress hormone.)
Human research routinely demonstrates these benefits and
suggests the usefulness of a combination with DHA, e.g.,
“The results demonstrate that consumption of 100 mg/day of
PS-DHA might be associated with improving or maintaining
cognitive status in elderly subjects with memory complaints.”12
Finally, there is the issue of the relation between Alzheimer’s
and sugar consumption. In old age, there tends to be an
increasingly significant association between forms of cognitive
impairment and depression. Some believe there’s a connection
between sugar intake and Alzheimer’s disease. There are a
number of theories as to why this might be. One argument is
that increased consumption of simple carbohydrates leads to
blood brain barrier degradation and subsequently to damage
to the hippocampus.13 A related argument is that increased
consumption of simple carbohydrates leads to elevations of
specific advanced glycation end products (AGEs), especially
the neurotoxic methyl-glyoxal derivatives (MG). High levels
of AGEs also are correlated with reduced insulin sensitivity in
older human adults. These factors promote chronic oxidant
stress and inflammation in the brain.14
Endnotes:
- Lavretsky H, Alstein LL, Olmstead RE, Ercoli LM, Riparetti-Brown M, Cyr NS, Irwin MR. Complementary use of tai chi chih augments escitalopram treatment of geriatric depression: a randomized controlled trial. Am J Geriatr Psychiatry. 2011 Oct;19(10):839–50.
- Gartlehner G, Gaynes BN, Amick HR, Asher G, Morgan LC, Coker- Schwimmer E, Forneris C, Boland E, Lux LJ, Gaylord S, Bann C, Pierl CB, Lohr KN. Nonpharmacological Versus Pharmacological Treatments for Adult Patients With Major Depressive Disorder [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2015 Dec.
- Gartlehner G, Gaynes BN, Amick HR, Asher GN, Morgan LC, Coker- Schwimmer E, Forneris C, Boland E, Lux LJ, Gaylord S, Bann C, Pierl CB, Lohr KN. Comparative Benefits and Harms of Antidepressants, Psychological, Complementary, and Exercise Treatments for Major Depression: An Evidence Report for a Clinical Practice Guideline From the American College of Physicians. Ann Intern Med. 2016 Feb 9. [Epub ahead of print]
- Barnum CJ, Pace TW, Hu F, Neigh GN, Tansey MG. Psychological stress in adolescent and adult mice increases neuroinflammation and attenuates the response to LPS challenge. J Neuroinflammation. 2012 Jan 16;9:9.
- Wager-Smith K, Markou A. Depression: a repair response to stress-induced neuronal microdamage that can grade into a chronic neuroinflammatory condition? Neurosci Biobehav Rev. 2011 Jan;35(3):742–64.
- Cherniack EP. A berry thought-provoking idea: the potential role of plant polyphenols in the treatment of age-related cognitive disorders. Br J Nutr. 2012 Sep;108(5):794–800.
- Sánchez-Villegas A, Henríquez-Sánchez P, Ruiz-Canela M, Lahortiga F, Molero P, Toledo E, Martínez-González MA. A longitudinal analysis of diet quality scores and the risk of incident depression in the SUN Project. BMC Med. 2015 Sep 17;13:197.
- Chang J, Rimando A, Pallas M, Camins A, Porquet D, Reeves J, Shukitt- Hale B, Smith MA, Joseph JA, Casadesus G. Low-dose pterostilbene, but not resveratrol, is a potent neuromodulator in aging and Alzheimer’s disease. Neurobiol Aging. 2012 Sep;33(9):2062–71.
- Cherniack EP. A berry thought-provoking idea: the potential role of plant polyphenols in the treatment of age-related cognitive disorders. Br J Nutr. 2012 Sep;108(5):794–800.
- Zheng M, Fan Y, Shi D, Liu C. Antidepressant-like effect of flavonoids extracted from Apocynum venetum leaves on brain monoamine levels and dopaminergic system. J Ethnopharmacol. 2013 May 2;147(1):108–13.
- Butterweck V, Nishibe S, Sasaki T, Uchida M. Antidepressant effects of apocynum venetum leaves in a forced swimming test. Biol Pharm Bull. 2001 Jul;24(7):848–51.
- Vakhapova V, Cohen T, Richter Y, Herzog Y, Kam Y, Korczyn AD. Phosphatidylserine containing omega-3 Fatty acids may improve memory abilities in nondemented elderly individuals with memory complaints: results from an open-label extension study. Dement Geriatr Cogn Disord. 2014;38(1–2):39–45.
- Hsu TM, Kanoski SE. Blood-brain barrier disruption: mechanistic links between Western diet consumption and dementia. Front Aging Neurosci. 2014 May 9;6:88.
- Cai W, Uribarri J, Zhu L, Chen X, Swamy S, Zhao Z, Grosjean F, Simonaro C, Kuchel GA, Schnaider-Beeri M, Woodward M, Striker GE, Vlassara H. Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans. Proc Natl Acad Sci U S A. 2014 Apr 1;111(13):4940–5.